2D-CuPd nanozyme overcome tamoxifen resistance in breast cancer by regulating the PI3K/AKT/mTOR pathway
Wenwei Jiang(Nanfang Hospital), Guangyu Yao(University of Science and Technology of China), Suqin Zhong(Guangdong General Hospital), Ziying Chen(Shanghai University of Traditional Chinese Medicine), Hao Zhang(Harbin Institute of Technology), Jieying Qian(Guangzhou First People's Hospital), Yunjiao Zhang(South China University of Technology), Xiaowan Huang(South China University of Technology), Longping Wen(Guangdong Academy of Medical Sciences)
Cited by 50
Related Papers
Targeting the brain with PEG–PLGA nanoparticles modified with phage-displayed peptides
|Biomaterials|2011|289
Harnessing copper-palladium alloy tetrapod nanoparticle-induced pro-survival autophagy for optimized photothermal therapy of drug-resistant cancer
|Nature Communications|2018|209
Digital twins-based flexible operating of open architecture production line for individualized manufacturing
|Advanced Engineering Informatics|2022|108
Enhancing anti-tumor effect of ultrasensitive bimetallic RuCu nanoparticles as radiosensitizers with dual enzyme-like activities
|Biomaterials|2022|71
Impact of Morphology on Iron Oxide Nanoparticles-Induced Inflammasome Activation in Macrophages
|ACS Applied Materials & Interfaces|2018|63